US7459566B2ExpiredUtilityA1
1,2,4-oxadiazol-5-one-4-(benzimidazolylmethylamino)benzamidine compounds
Est. expiryJun 25, 2024(expired)· nominal 20-yr term from priority
Inventors:Georg ZerbanArndt HausherrKerstin SchlarbHeinz-Peter SchmittBjoern WeyellGunter KochRainer Hamm
A61P 7/02A61P 9/08C07D 271/07C07D 401/12C07D 413/14C07D 235/14
85
PatentIndex Score
11
Cited by
11
References
4
Claims
Abstract
A process for preparing an optionally substituted 4-benzimidazol-2-ylmethylamino)benzamidine, the process comprising: (a) condensing an optionally suitably substituted diaminobenzene with 2-[4-(1,2,4-oxadiazol-5-on-3-yl)phenylamino]acetic acid; (b) hydrogenating the product obtained from step (a); and (c) optionally carboxylating the amidino group of the product obtained from step (b).
Claims
exact text as granted — not AI-modified1. A compound of formula (III)
wherein:
R 1 is a C 1-6 -alkyl or C 3-7 -cycloalkyl group; and
R 2 is
(i) a C 1-6 -alkyl group or a C 3-7 -cycloalkyl group optionally substituted by a C 1-3 -alkyl group, wherein the C 1-3 -alkyl group is optionally substituted by a carboxyl group or
(ii) an R 21 NR 22 group, wherein:
R 21 is a C 1-6 alkyl group optionally substituted by a carboxy, C 1-6 alkoxycarbonyl, benzyloxycarbonyl, C 1-3 -alkylsulfonylaminocarbonyl, phenylsulfonylaminocarbonyl, trifluorosulfonylamino, trifluorosulfonylaminocarbonyl, or 1H-tetrazolyl group, a C 2-4 -alkyl group substituted by a hydroxy, phenyl-C 1-3 -alkoxy, carboxy-C 1-3 -alkylamino, C 1-3 -alkoxycarbonyl-C 1-3 -alkylamino, N-(C 1-3 -alkyl)-carboxy-C 1-3 -alkylamino, or N-(C 1-3 -alkyl)-C 1-3 -alkoxycarbonyl-C 1-3 -alkylamino group, wherein the α-carbon atom to the adjacent nitrogen atom thereof is not substituted, or a piperidinyl group optionally substituted by a C 1-3 -alkyl group, and
R 22 is a hydrogen atom,
a C 1-6 -alkyl group,
a C 3-7 -cycloalkyl group optionally substituted by a C 1-3 -alkyl group,
a C 3-6 -alkenyl, or C 3-6 -alkynyl group, wherein an unsaturated moiety of the C 3-6 -alkenyl or C 3-6 -alkynyl group is not linked directly to the nitrogen atom of the R 21 NR 22 group,
a phenyl group optionally substituted by a fluorine, chlorine, or bromine atom or by a C 1-3 -alkyl or C 1-3 -alkoxy group, or
a benzyl, oxazolyl, isoxazolyl, thiazolyl, isothiazolyl, pyrazolyl, pyridinyl, pyrimidinyl, pyrazinyl, pyridazinyl, pyrrolyl, thienyl, or imidazolyl group optionally substituted by a C 1-3 -alkyl group; or
R 21 and R 22 together with the nitrogen atom between them are a 5- to 7-membered cycloalkyleneimino group optionally substituted by a carboxy or C 1-4 -alkoxycarbonyl group, to which a phenyl ring is optionally additionally fused.
2. The compound of formula (III) according to claim 1 , wherein:
R 1 is a C 1-3 -alkyl group; and
R 2 is an R 21 NR 22 group, wherein:
R 21 is a C 1-3 alkyl group optionally substituted by a carboxy or C 1-3 alkoxycarbonyl, and
R 22 is a hydrogen atom, a C 1-3 -alkyl group, or a pyridyl group optionally substituted by a C 1-3 -alkyl group.
3. The compound of formula (III) according to claim 2 , wherein:
R 1 is a methyl group;
R 2 is an R 21 NR 22 group, wherein:
R 21 is an ethyl group substituted by an ethoxycarbonyl group, and
R 22 is a pyridin-2-yl group.
4. 2-[4-(1,2,4-Oxadiazol-5-one-3-yl)phenylamino]acetic acid.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.